or Try an Advanced Search...

    Technical Analysis for NAUT - Nautilus Biotechnology, Inc.

    Grade Last Price % Change Price Change
    C 2.74 3.79% 0.10
    NAUT closed up 3.79 percent on Friday, May 31, 2024, on 3.26 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    Earnings due: Jun 13
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical NAUT trend table...
    Date Alert Name Type % Chg
    Crossed Above 50 DMA Bullish 0.00%
    Stochastic Buy Signal Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    50 DMA Resistance Bearish 3.79%
    Bollinger Band Squeeze Range Contraction 3.79%
    Oversold Stochastic Weakness 3.79%
    Older End-of-Day Signals for NAUT ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Resistance 1 day ago
    10 DMA Resistance 1 day ago
    Up 3% 1 day ago
    Up 2% 1 day ago
    Up 1% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    NAUT Chart by TradingView
    Basic chart:

    Profile

    Nautilus Biotechnology, Inc. operates as biotech company that develops a platform using computational techniques, cloud computing, AI technologies, and blood tests to detect cancer and potentially other health issues at an early stage. Nautilus Biotechnology, Inc. was formerly known as Ignite Biosciences, Inc. The company was incorporated in 2016 and is based in San Carlos, California.
    Classification
    Sector: Industrials
    Industry: Conglomerates
    Keywords: Biotechnology Cancer Cloud Computing Software Ai Technologies

    Is NAUT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 23 Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
    May 2 We're Hopeful That Nautilus Biotechnology (NASDAQ:NAUT) Will Use Its Cash Wisely
    May 1 Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings Call Transcript Highlights: A Detailed ...
    Apr 30 Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call Transcript
    Apr 30 Nautilus Biotechnology GAAP EPS of -$0.15 beats by $0.01
    Apr 30 Nautilus Biotechnology Reports First Quarter 2024 Financial Results
    Apr 30 Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings: Narrower Loss Than Expected
    Apr 11 Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
    Mar 11 This Nautilus Biotechnology Insider Increased Their Holding In The Last Year
    Feb 28 Nautilus Biotechnology files $300M mixed securities shelf
    See more NAUT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.65
    52 Week Low 2.3
    Average Volume 67,292
    200-Day Moving Average 2.87
    50-Day Moving Average 2.66
    20-Day Moving Average 2.75
    10-Day Moving Average 2.72
    Average True Range 0.14
    RSI (14) 52.15
    ADX 15.87
    +DI 20.04
    -DI 20.66
    Chandelier Exit (Long, 3 ATRs) 2.55
    Chandelier Exit (Short, 3 ATRs) 2.95
    Upper Bollinger Bands 2.96
    Lower Bollinger Band 2.55
    Percent B (%b) 0.47
    BandWidth 14.81
    MACD Line 0.00
    MACD Signal Line 0.02
    MACD Histogram -0.0207
    Fundamentals Value
    Market Cap 342.42 Million
    Num Shares 125 Million
    EPS -0.47
    Price-to-Earnings (P/E) Ratio -5.83
    Price-to-Sales 0.00
    Price-to-Book 1.22
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.86
    Resistance 3 (R3) 2.85 2.79 2.84
    Resistance 2 (R2) 2.79 2.76 2.80 2.83
    Resistance 1 (R1) 2.77 2.74 2.78 2.78 2.83
    Pivot Point 2.71 2.71 2.72 2.72 2.71
    Support 1 (S1) 2.69 2.68 2.70 2.70 2.65
    Support 2 (S2) 2.63 2.66 2.64 2.65
    Support 3 (S3) 2.61 2.63 2.64
    Support 4 (S4) 2.62